Curis Inc (CRIS) stock
CRISNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3091% below fair value
$0.47−0.14 (-23.59%)
Close on Nov 19, 2026Market cap $981.08KP/E –Yield –
Curis revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Curis's revenue for the twelve months ending Jun 30, 2026 was $4.31M, down 62.2% year over year. For fiscal 2025 it was $9.44M, down 13.4% from the year before. Over ten years it grew 1.8% a year on average. The highest annual figure on record is $16.97M in fiscal 2012.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.44M | -13.4% |
| FY2024 | Dec 31, 2024 | $10.91M | +8.8% |
| FY2023 | Dec 31, 2023 | $10.02M | -1.4% |
| FY2022 | Dec 31, 2022 | $10.16M | -4.6% |
| FY2021 | Dec 31, 2021 | $10.65M | -1.7% |
| FY2020 | Dec 31, 2020 | $10.84M | +8.3% |
| FY2019 | Dec 31, 2019 | $10.00M | -4.1% |
| FY2018 | Dec 31, 2018 | $10.43M | +5.4% |
| FY2017 | Dec 31, 2017 | $9.90M | +31.5% |
| FY2016 | Dec 31, 2016 | $7.53M | -4.5% |
| FY2015 | Dec 31, 2015 | $7.88M | -20.0% |
| FY2014 | Dec 31, 2014 | $9.84M | -34.4% |
| FY2013 | Dec 31, 2013 | $15.00M | -11.6% |
| FY2012 | Dec 31, 2012 | $16.97M | +15.0% |
| FY2011 | Dec 31, 2011 | $14.76M | -7.7% |
| FY2010 | Dec 31, 2010 | $16.00M | +86.3% |
| FY2009 | Dec 31, 2009 | $8.59M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | -100.0% |
| Q1 FY2026 | Mar 31, 2026 | $0 | -100.0% |
| Q4 FY2025 | Dec 31, 2025 | $1.14M | -66.0% |
| Q3 FY2025 | Sep 30, 2025 | $3.18M | +8.4% |
| Q2 FY2025 | Jun 30, 2025 | $2.75M | +8.0% |
| Q1 FY2025 | Mar 31, 2025 | $2.38M | +14.1% |
| Q4 FY2024 | Dec 31, 2024 | $3.35M | +24.1% |
| Q3 FY2024 | Sep 30, 2024 | $2.93M | +3.5% |
| Q2 FY2024 | Jun 30, 2024 | $2.55M | +15.9% |
| Q1 FY2024 | Mar 31, 2024 | $2.09M | -9.2% |
| Q4 FY2023 | Dec 31, 2023 | $2.70M | -6.6% |
| Q3 FY2023 | Sep 30, 2023 | $2.83M | +0.3% |
| Q2 FY2023 | Jun 30, 2023 | $2.20M | -8.2% |
| Q1 FY2023 | Mar 31, 2023 | $2.30M | +11.7% |
| Q4 FY2022 | Dec 31, 2022 | $2.89M | -7.9% |
| Q3 FY2022 | Sep 30, 2022 | $2.83M | -7.0% |
| Q2 FY2022 | Jun 30, 2022 | $2.39M | +4.7% |
| Q1 FY2022 | Mar 31, 2022 | $2.06M | -6.0% |
| Q4 FY2021 | Dec 31, 2021 | $3.14M | +3.7% |
| Q3 FY2021 | Sep 30, 2021 | $3.04M | +10.8% |
| Q2 FY2021 | Jun 30, 2021 | $2.29M | -3.1% |
| Q1 FY2021 | Mar 31, 2021 | $2.19M | -19.2% |
| Q4 FY2020 | Dec 31, 2020 | $3.02M | -8.0% |
| Q3 FY2020 | Sep 30, 2020 | $2.74M | -4.0% |
| Q2 FY2020 | Jun 30, 2020 | $2.36M | +12.7% |
| Q1 FY2020 | Mar 31, 2020 | $2.71M | +53.3% |
| Q4 FY2019 | Dec 31, 2019 | $3.29M | +19.3% |
| Q3 FY2019 | Sep 30, 2019 | $2.86M | +0.3% |
| Q2 FY2019 | Jun 30, 2019 | $2.09M | -11.2% |
| Q1 FY2019 | Mar 31, 2019 | $1.77M | -28.4% |
| Q4 FY2018 | Dec 31, 2018 | $2.76M | -15.5% |
| Q3 FY2018 | Sep 30, 2018 | $2.85M | +16.5% |
| Q2 FY2018 | Jun 30, 2018 | $2.36M | +14.4% |
| Q1 FY2018 | Mar 31, 2018 | $2.47M | +15.8% |
| Q4 FY2017 | Dec 31, 2017 | $3.26M | +38.1% |
| Q3 FY2017 | Sep 30, 2017 | $2.44M | +38.9% |
| Q2 FY2017 | Jun 30, 2017 | $2.06M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.13M | – |
| Q4 FY2016 | Dec 31, 2016 | $2.36M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.76M | – |
See a number that looks wrong?